Entity
  • IDEA Pharma | From R&D to RxD

    Created in 2000
  • Social networks

    7,177 17,413
  • Activities

  • Entity types

  • Location

    Cranfield, Bedford MK43 0FQ, UK

    Cranfield

    United Kingdom

  • Employees

    Scale: 51-200

    Estimated: 38

  • Engaged corporates

    15
    3 8
  • Added in Motherbase

    5 years ago
Description
  • Value proposition

    Path-to-Market Strategy | #RxD

    Who? Pharma's experts in path-to-market strategy, positioning and applied innovation.

    What? IDEA Pharma is a Path-To-Market Strategy practice. Applied Design Thinking in early phase.

    Where? Offices in UK & New York City, working with clients globally.

    Why? Choosing a path to market successfully is a discipline, and like any discipline, it is best performed by specialists. Pharma works with IDEA to develop options for the 'best'​ path to market: clinically and commercially. IDEA supported the strategic direction and positioning for 8 out of the top 15 pharma product launches between 2015-2020. No other company comes close.

    IDEA has been lucky enough to work with some of the best product teams in the industry, and we will only engage if we believe in the client team. It's a philosophy that has ensured we love what we do, and that we can make the kind of difference that matters,.

    How? Areas of industry leadership include:
    • Strategic Positioning
    • Portfolio/ disease area Strategy
    • Value Proposition
    • Scenario planning, Strategy pressure test
    • Communication Strategy

    The path-to-market for a medicine is never obvious, so we develop design options: IDEAs that meet every hurdle: clinical, regulatory, and the important commercial hurdles (market access, reimbursement, competitor differentiation...). Clearing any one is relatively easy; clearing all of them is hard.

    A thousand things can influence the trajectory of a product: choice of indication, patient population, patient profile, line of therapy, trial endpoints, and many more.

    Products are the result of design decisions. When design is valued, great things happen.

    Sign up to our IDEA Junkie Newsletter to get more insight into what we do and how we think: https://mailchi.mp/ideapharma.com/junkie-sign-up

    Strategic marketing, disease area strategy, Scenario planning, differentiation, Communication strategy, Advisory meeting, IDEAtion, Path-to-medicine strategy, and Path to Market Strategy

Corporate interactions BETA
Corporate TypeTweets Articles
Pfizer
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Pfizer
Pharmaceutical, Pharmaceutical Manufacturing
Other

6 Apr 2024


Sanofi
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Sanofi
Pharmaceutical, Pharmaceutical Manufacturing
Other

13 Apr 2024


MSD
MSD
Pharmaceutical, Pharmaceutical Manufacturing
MSD
Pharmaceutical, Pharmaceutical Manufacturing
Other

27 Aug 2020


Mahindra Group
Mahindra Group
Executive Offices
Mahindra Group
Executive Offices
Other

2 Nov 2020


MassChallenge
MassChallenge
Startup accelerator & VC, Venture Capital and Private Equity Principals
MassChallenge
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

15 Jan 2020


Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Other

12 Nov 2023


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Other

8 Nov 2021


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

25 Nov 2022

31 Jan 2024



Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Pharmaceutical, Biotechnology, Biotechnology Research
Alexion Pharmaceuticals, Inc.
Pharmaceutical, Biotechnology, Biotechnology Research
Not capitalistic
Not partnership
Event

11 Jan 2020


NHS England
NHS England
Insurance, Hospitals and Health Care
NHS England
Insurance, Hospitals and Health Care
Other

2 Oct 2019


Similar entities
Loading...
Loading...
Social network dynamics